Basic Arcoxia Information

• INN (International Nonproprietary Name): Etoricoxib
• Brand Names Available In United Kingdom: Arcoxia (Merck/MSD) — other international brands in the raw data include Exinef and Nucoxia
• ATC Code: M01AH05
• Forms & Dosages: Film-coated tablet; strengths 30 mg, 60 mg, 90 mg, 120 mg; common pack sizes 7, 14, 28 or 30 tablets
• Manufacturers In United Kingdom: not specified
• Registration Status In United Kingdom: not specified
• OTC / Rx Classification: Prescription only (Rx)

Are you starting Arcoxia and want the must-know points first?

Follow your prescriber’s dose and duration because Arcoxia (etoricoxib) is prescription-only in the UK and regulated by the MHRA.

Etoricoxib is supplied as Arcoxia film-coated tablets in strengths 30 mg, 60 mg, 90 mg and 120 mg and should not be self-prescribed.

Avoid etoricoxib if you have uncontrolled high blood pressure, heart failure, recent stroke, active peptic ulcer or severe liver or renal disease; these are absolute contraindications in the product information.

Report chest pain, sudden breathlessness, black stools or severe abdominal pain immediately to your GP or emergency services.

Day-to-day, take the lowest effective dose for the shortest time, keep tablets in the original blister and store below 30°C.

Ask your community pharmacist at Boots, LloydsPharmacy or Superdrug for side-effect advice and how to report suspected reactions via the MHRA Yellow Card scheme.

Quick checklist for warning signs: chest pain; new shortness of breath; sudden swelling or rapid weight gain; black or bloody stools; severe abdominal pain.

Everyday Use & Best Practices

Morning Vs Evening Dosing

Which time of day is best depends on your symptoms and the condition being treated.

For chronic conditions such as osteoarthritis, rheumatoid arthritis or ankylosing spondylitis once-daily dosing is usual, often 60 mg for osteoarthritis and 90 mg for rheumatoid arthritis or ankylosing spondylitis.

If stiffness and pain are worse first thing, taking etoricoxib in the morning usually helps daytime function.

If pain disturbs sleep or peaks overnight an evening dose may be preferred to improve rest.

Consistency matters: take etoricoxib at roughly the same time each day for steady effect.

For short-term acute pain such as dental pain, gout flare or primary dysmenorrhoea single daily doses of 90–120 mg are typical, with prescriber limits (for example gout usually capped at eight days).

• Osteoarthritis: 60 mg once daily.
• Rheumatoid arthritis / Ankylosing spondylitis: 90 mg once daily.
• Acute gout/dental pain/dysmenorrhoea: 90–120 mg once daily for short term as instructed.

Taking With Or Without Meals (UK Diet Habits)

Etoricoxib is rapidly absorbed and may be taken with or without food.

If you get dyspepsia on a typical UK diet of brewed tea, coffee or fatty meals, taking the tablet with food or a small amount of milk can reduce stomach upset.

Avoid heavy alcohol while taking etoricoxib because alcohol increases the risk of gastrointestinal bleeding and may worsen blood-pressure effects.

Keep well hydrated, particularly in hot weather or when taking diuretics, to protect kidney function.

Checklist:

• Take with food or milk if you have indigestion.
• Avoid excess alcohol while on etoricoxib.
• Maintain hydration, especially if on diuretics.

Safety Priorities

Who Should Avoid It (MHRA Warnings)

Who must not take etoricoxib is key to safe use and follows the product information and MHRA cautions.

• Hypersensitivity to etoricoxib or any excipients.
• History of NSAID‑induced asthma, urticaria or angioedema.
• Active peptic ulcer disease or current gastrointestinal bleeding.
• Severe hepatic dysfunction.
• Creatinine clearance less than 30 mL/min (severe renal impairment).
• Uncontrolled hypertension (blood pressure consistently >140/90 mmHg).
• Congestive heart failure, ischaemic heart disease, cerebrovascular or peripheral arterial disease.
• Pregnancy or lactation and children under 16 years.
• Concurrent use with other NSAIDs (including high-dose aspirin).

Activities To Limit (Driving, Work Safety)

Etoricoxib can cause dizziness or headache in some people and this affects safety-critical tasks.

Avoid driving, cycling or operating heavy machinery if you feel dizzy, light-headed or drowsy after taking the tablet.

For safety‑critical jobs such as transport, construction or roles requiring high concentration, discuss temporary workplace adjustments with your employer and prescriber.

Limit alcohol while taking etoricoxib because it may increase drowsiness and GI risk.

Report new swelling, rapid unexplained weight gain or breathlessness promptly as these may be signs of fluid retention or cardiac strain.

Dosage & Adjustments

General Regimen (NHS Guidance)

NHS prescribers tend to follow the licensed dosing in the product information for etoricoxib.

Typical adult doses are: osteoarthritis 60 mg once daily, rheumatoid arthritis and ankylosing spondylitis 90 mg once daily, and acute gout or short-term acute pain up to 120 mg once daily for the indicated short duration.

Prescribers aim for the minimum effective dose and the shortest possible duration, with periodic review if the drug is continued long term.

Special Cases (Elderly, Comorbidities)

Elderly patients do not require routine dose change for etoricoxib, but monitoring is essential due to higher cardiovascular and renal risk.

For mild liver impairment restrict the dose to a maximum of 60 mg daily and for moderate impairment a maximum of 30 mg daily; severe hepatic impairment is contraindicated.

Severe renal impairment (creatinine clearance <30 mL/min) is contraindicated while mild to moderate renal dysfunction can be managed with close monitoring.

Children under 16 years should not use etoricoxib.

Monitoring checklist:

• Baseline and periodic blood pressure checks.
• Renal function and liver function tests as clinically indicated.
• Weight checks and assessment for peripheral oedema.

User Testimonials

Positive Reports From UK Patients

What do patients say when they try Arcoxia for arthritis or flares?

Many UK discussion pages report fast and reliable pain relief, often within a day due to etoricoxib’s rapid absorption.

Patients on 60–90 mg for arthritis commonly describe improved mobility and better sleep because pain at night is reduced.

Users with previous stomach problems often note better stomach tolerance compared with non‑selective NSAIDs, consistent with COX‑2 selectivity.

• Faster pain control and improved sleep reported by arthritis patients.
• Fewer troublesome stomach ulcers compared with some other NSAIDs reported anecdotally.
• Helpful pharmacist counselling at Boots or LloydsPharmacy appreciated by many patients.

Common Challenges (Patient.info, NHS Forums)

Not every experience is positive and patients commonly report trade-offs.

Typical downsides mentioned include mild dyspepsia, headaches and occasional rises in blood pressure requiring monitoring.

Some patients stopped treatment due to palpitations or noticeable swelling from fluid retention and needed alternative analgesia.

Access and cost can be a barrier; prescriptions in England carry a charge while Scotland, Wales and Northern Ireland generally have free prescriptions, which affects uptake.

When to contact your clinician:

• New or worsening breathlessness, chest pain or palpitations.
• Black stools or vomiting blood, severe abdominal pain.
• Marked swelling or rapid weight gain.

Buying Guide

Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)

Arcoxia is a prescription-only medicine and should be obtained through a GP or recognised prescriber and dispensed at community pharmacies such as Boots, LloydsPharmacy, Superdrug or independent chemists.

UK online pharmacies may dispense with a valid prescription and must be registered with the General Pharmaceutical Council.

Arcoxia tablets are supplied by MSD in Europe and are supplied in film-coated tablet strengths 30 mg, 60 mg, 90 mg and 120 mg; generics exist in some countries but verify the brand on the label.

Checklist for safe online purchase:

• Ensure the pharmacy requires and verifies a valid prescription.
• Confirm GPhC registration and clear contact details for pharmacist counselling.
• Check product labelling for Arcoxia or the INN etoricoxib and pack size.

Price Comparison (NHS Prescription Charge Vs Private)

Prescription charging differs across UK nations and can influence patient choices.

In England, prescriptions are charged per item at the current NHS prescription rate; Scotland, Wales and Northern Ireland generally provide free prescriptions for residents.

Private prescriptions vary by pharmacy and whether a branded Arcoxia or a generic etoricoxib product is dispensed; generics are usually less costly.

What’s Inside & How It Works

Ingredients Overview

The active substance is etoricoxib, the INN for Arcoxia tablets.

Arcoxia film-coated tablets are available in 30 mg, 60 mg, 90 mg and 120 mg strengths and commonly packed as boxes of 7, 14, 28 or 30 tablets.

Excipients differ by manufacturer and batch and may include substances that some patients are allergic to, so always check the patient leaflet if you have known allergies.

• Strengths: 30 mg, 60 mg, 90 mg, 120 mg.
• Pack sizes: Commonly 7, 14, 28 or 30 film-coated tablets.
• Manufacturer (global): Merck Sharp & Dohme (MSD) is the innovator.

Mechanism Basics Explained Simply

Etoricoxib is a COX‑2 selective inhibitor that reduces the production of prostaglandins involved in pain and inflammation.

Because it focuses mainly on COX‑2, etoricoxib typically causes fewer gastrointestinal ulcers than non‑selective NSAIDs, but long-term or high-dose use is associated with an increased cardiovascular risk.

Main Indications

Approved Uses (MHRA Listing)

Etoricoxib is licensed for a range of musculo-skeletal and acute pain indications following the product information.

Off‑Label Uses In UK Clinics

Specialist pain or perioperative clinics may use COX‑2 agents off‑label in specific circumstances, but this must be documented and justified.

COX‑2 selectivity is sometimes chosen when gastrointestinal risk is significant and alternatives are unsuitable, with informed consent recorded.

Checklist for off‑label prescribing:

• Document clinical rationale and discuss risks and benefits with the patient.
• Record baseline cardiovascular and renal checks where appropriate.
• Plan follow-up monitoring and review dates clearly in the patient record.

Interaction Warnings

Food Interactions (Alcohol, Tea/Coffee)

There are no major food–drug interactions noted for etoricoxib, but alcohol increases gastrointestinal bleeding risk and may exacerbate blood-pressure effects.

High caffeine intake from tea or coffee can worsen dyspepsia in some people, so taking the tablet with food may help reduce stomach upset.

Maintain good hydration while taking etoricoxib, particularly if you are taking diuretics or live a physically active life in hot weather.

• Avoid excess alcohol while taking etoricoxib.
• Take with food or milk if you experience indigestion linked to tea or coffee intake.
• Stay hydrated to support renal function.

Drug Conflicts (MHRA Yellow Card Reports)

Etoricoxib must not be combined with other NSAIDs, including high-dose aspirin, due to additive gastrointestinal, renal and cardiovascular risk.

Caution is required with anticoagulants and SSRIs because of increased bleeding risk, and with ACE inhibitors, ARBs, diuretics and lithium as renal function or drug levels may be affected.

If you suspect an interaction or unexpected effect report it via the MHRA Yellow Card scheme and ask your pharmacist to review your medication list.

• Avoid: other NSAIDs and high‑dose aspirin.
• Caution with: anticoagulants, SSRIs, ACE inhibitors/ARBs, diuretics, lithium.
• Seek pharmacist review for complex polypharmacy.

Latest Evidence & Insights

Key UK & EU Studies 2022–2025

Recent cohort studies and meta-analyses from 2022–2025 reinforce the efficacy of COX‑2 selective agents like etoricoxib for analgesia with reduced GI adverse events versus non‑selective NSAIDs.

These analyses consistently demonstrate an elevated risk of major adverse cardiovascular events associated with long-term or high-dose COX‑2 use, supporting conservative long-term prescribing practises.

• COX‑2 agents provide effective pain control and fewer GI ulcers compared with non‑selective NSAIDs.
• Long-term/high-dose use increases cardiovascular risk, requiring strict risk assessment.
• Evidence underlines using the lowest effective dose and frequent monitoring for chronic therapy.

Practical Takeaways For UK Prescribers And Patients

Before starting long-term etoricoxib carry out cardiovascular risk scoring and baseline blood pressure, renal and liver checks as appropriate.

For patients, report chest pain, dyspnoea, sudden swelling, black stools or other worrying changes promptly.

Local NHS formularies and MHRA safety communications should guide any updates to prescribing practice.

Monitoring checklist:

• Baseline BP, renal and liver tests before chronic treatment.
• Regular review of dose, symptoms and adverse effects.
• Document family history of cardiac disease as part of risk assessment.

Alternative Choices

NHS Prescribing Alternatives

When etoricoxib is unsuitable, NHS options include other COX‑2 inhibitors such as celecoxib where available, non‑selective NSAIDs like ibuprofen or naproxen, and paracetamol for milder pain.

Choice depends on the balance of gastrointestinal versus cardiovascular risk and individual comorbidities.

Topical NSAIDs can be a useful alternative for localized osteoarthritis pain and reduce systemic exposure.

Pros/Cons Checklist

Pros of etoricoxib include effective pain relief and generally better gastric tolerability than non‑selective NSAIDs due to COX‑2 selectivity.

Cons include a raised cardiovascular risk with long-term or high-dose use and multiple absolute contraindications for people with heart or severe renal or hepatic disease.

When switching therapies document the reasons clearly and monitor for new adverse events after any change.

Regulation Snapshot

MHRA Approval & UK Status

Etoricoxib belongs to the coxib class with ATC code M01AH05 and is authorised in many countries according to the product information.

The raw data shows approval in over 60 countries including EU territories and that Arcoxia is a prescription-only medicine; specific UK registration details are not specified in the raw data provided.

Note that in other jurisdictions etoricoxib may not be approved, illustrating national regulatory differences.

• ATC: M01AH05 (COX‑2 inhibitors).
• Arcoxia is marketed by MSD in many territories.
• Classified as prescription-only across markets in the raw data.

NHS Prescribing Framework

Prescribers must document indication, dose and duration and perform baseline cardiovascular, renal and hepatic checks where relevant.

Repeat prescribing should include regular reviews of efficacy, adverse effects and consideration of step-down to the lowest effective dose.

Suspected adverse drug reactions should be reported to the MHRA Yellow Card scheme and recorded in the patient’s notes.

Prescribers should check local NHS formularies for specific advice and any restrictions on COX‑2 prescribing.

FAQ Section

Can I Get Arcoxia Over The Counter?

No — Arcoxia (etoricoxib) is prescription-only in the UK and a valid prescription is required for supply.

What If I Miss A Dose Or Overdose?

If you miss a dose take it as soon as remembered unless it is close to the next dose; do not double up to make up a missed dose.

In the event of an overdose there is no specific antidote and treatment is supportive; seek urgent medical attention and contact NHS 111 or emergency services for severe symptoms.

Is It Safe Long Term?

Long-term use raises cardiovascular and renal risks and should only continue with explicit prescriber review and regular monitoring.

Monitoring steps include routine blood pressure checks, periodic renal and liver function tests and assessment for oedema or weight gain.

Guidelines For Proper Use

UK Pharmacist Counselling Style

A pharmacist should confirm the indication, intended dose and duration and check medical history for cardiovascular, renal, hepatic and gastrointestinal risks.

Review concomitant medicines that increase bleeding or renal risks such as anticoagulants, SSRIs, ACE inhibitors or diuretics.

Advise on common side-effects including dyspepsia, headache, dizziness and fluid retention and explain when to seek urgent care.

Provide written patient advice and encourage reporting of suspected adverse reactions via the Yellow Card scheme.

• Confirm indication and duration.
• Check for contraindications and interacting medicines.
• Give clear advice on warning signs and Yellow Card reporting.

NHS Patient Support Advice

Arrange baseline and follow-up blood pressure and renal/liver function checks per local NHS protocol when using etoricoxib chronically.

Discuss prescription costs and exemption status with the patient as applicable to England, Scotland, Wales or Northern Ireland.

For ongoing function or insufficient analgesia refer patients to physiotherapy, weight management services or specialist pain clinics as appropriate.

Keep a medication card listing etoricoxib (strength and brand) for travel or secondary care visits.

Delivery Across United Kingdom

Medication note: Arcoxia (etoricoxib) is prescription-only and should be supplied with a valid prescription.

If you need help obtaining a prescription ask your GP or use a registered online prescriber linked to a legitimate pharmacy service.

For any side-effects or suspected interactions your community pharmacist can provide immediate advice and help report concerns to the MHRA Yellow Card scheme.